Skip Navigation

JNCI Journal of the National Cancer Institute 2007 99(8):577; doi:10.1093/jnci/djk169
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Japanese Translation
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2007.

IN THIS ISSUE

The first 10% of the full text of this article appears below.

Adverse Drug Interactions Among Cancer Patients

Cancer patients typically receive numerous medications, including chemotherapeutic agents, drugs for supportive care, and treatments for conditions that coexist with the cancer. Riechelmann et al. (p. 592) report on the extent to which drug combinations with the potential for adverse reactions were prescribed to a sample of adult cancer patients receiving chemotherapy. Potential adverse interactions were identified using a computer software program that searched a database on drug interactions compiled from the published literature. At least one potentially adverse drug interaction was identified in 27% of the surveyed patients. The majority . . . [Full Text of this Article]

Assessment of Chemotherapy for High-risk Gastric Cancer Patients

Long-Term Daily Use of Adult-Strength Aspirin and Cancer Risk

EGFR and Notch Signaling Pathways in Primary DCIS

p95HER2 and HER2-targeted Breast Cancer Therapies

Stathmin and Resistance of Malignant Gliomas to Nitrosoureas


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

Patient Safety in Cancer Care: A Time for Action
Peter G. Norton and G. Ross Baker
J Natl Cancer Inst 2007 99: 579-580. [Extract] [Full Text] [PDF]

Adjuvant Therapy for Gastric Cancer: How Negative Results Can Help Patients
Susan S. Ellenberg and Weijing Sun
J Natl Cancer Inst 2007 99: 580-582. [Extract] [Full Text] [PDF]

More Aspirin for Less Cancer?
María Elena Martínez and E. Robert Greenberg
J Natl Cancer Inst 2007 99: 582-583. [Extract] [Full Text] [PDF]

Potential Drug Interactions and Duplicate Prescriptions Among Cancer Patients
Rachel P. Riechelmann, Ian F. Tannock, Lisa Wang, Everardo D. Saad, Nathan A. Taback, and Monika K. Krzyzanowska
J Natl Cancer Inst 2007 99: 592-600. [Abstract] [Full Text] [PDF]

Adjuvant Treatment of High-Risk, Radically Resected Gastric Cancer Patients With 5-Fluorouracil, Leucovorin, Cisplatin, and Epidoxorubicin in a Randomized Controlled Trial
Stefano Cascinu, Roberto Labianca, Carlo Barone, Armando Santoro, Carlo Carnaghi, Alessandra Cassano, Giordano D. Beretta, Vincenzo Catalano, Oscar Bertetto, Sandro Barni, Luciano Frontini, Enrico Aitini, Silvia Rota, Valter Torri, and Irene Floriani
J Natl Cancer Inst 2007 99: 601-607. [Abstract] [Full Text] [PDF]

A Large Cohort Study of Long-Term Daily Use of Adult-Strength Aspirin and Cancer Incidence
Eric J. Jacobs, Michael J. Thun, Elizabeth B. Bain, Carmen Rodriguez, S. Jane Henley, and Eugenia E. Calle
J Natl Cancer Inst 2007 99: 608-615. [Abstract] [Full Text] [PDF]

Novel Cell Culture Technique for Primary Ductal Carcinoma In Situ: Role of Notch and Epidermal Growth Factor Receptor Signaling Pathways
Gillian Farnie, Robert B. Clarke, Katherine Spence, Natasha Pinnock, Keith Brennan, Neil G. Anderson, and Nigel J. Bundred
J Natl Cancer Inst 2007 99: 616-627. [Abstract] [Full Text] [PDF]

Expression of p95HER2, a Truncated Form of the HER2 Receptor, and Response to Anti-HER2 Therapies in Breast Cancer
Maurizio Scaltriti, Federico Rojo, Alberto Ocaña, Judit Anido, Marta Guzman, Javier Cortes, Serena Di Cosimo, Xavier Matias-Guiu, Santiago Ramon y Cajal, Joaquin Arribas, and José Baselga
J Natl Cancer Inst 2007 99: 628-638. [Abstract] [Full Text] [PDF]

The 1p-Encoded Protein Stathmin and Resistance of Malignant Gliomas to Nitrosoureas
Teri-T B. Ngo, Tien Peng, Xing-Jie Liang, Oluwaseun Akeju, Sandra Pastorino, Wei Zhang, Yuri Kotliarov, Jean C. Zenklusen, Howard A. Fine, Dragan Maric, Patrick Y. Wen, Umberto De Girolami, Peter McL. Black, Wells W. Wu, Rong-Fong Shen, Neal O. Jeffries, Dong-Won Kang, and John K. Park
J Natl Cancer Inst 2007 99: 639-652. [Abstract] [Full Text] [PDF]